PKD2 and autosomal dominant polycystic kidney disease: Consistent with previous studies suggesting that AMPK activation is applicable for managing ADPKD and reducing renal cystogenesis, the current findings show that activation of the AMPK signaling pathways may be effective to delay tumor growth and renal cystogenesis with the low TRPP2 expression [37, 38].